Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis

Does metastasectomy improve survival in patients with stage IV melanoma? a cancer registry analysis of outcomes

(2011) Nabil Wasif et al.   JOURNAL OF SURGICAL ONCOLOGY

Predicting Survival Outcome of Localized Melanoma: An Electronic Prediction Tool Based on the AJCC Melanoma Database

(2010) Seng-jaw Soong et al.   ANNALS OF SURGICAL ONCOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma

(2009) Claus Garbe et al.   MELANOMA RESEARCH

Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders

(2009) M L Schroeter et al.   MOLECULAR PSYCHIATRY

A Single-Institution Validation of the AJCC Staging System for Stage IV Melanoma

(2008) Heather B. Neuman et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694

(2008) Ahmad A. Tarhini et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Survival Analysis in Metastatic Melanoma: Serum S100B Is an Independent Prognostic Marker and Superior to LDH

(2008) Friederike Egberts et al.   ONKOLOGIE